Literature DB >> 2603606

Sequelae of axillary dissection vs. axillary sampling with or without irradiation for breast cancer. A randomized trial.

S Borup Christensen1, E Lundgren.   

Abstract

One hundred women with operable breast cancer were randomized to two equal groups. In group A the aim was to remove all fat tissue in the axilla. In group B suspectedly pathologic nodes were removed, and if no nodes were palpable the lower half of the axillary fat was excised. Irrespective of this grouping, partial mastectomy was generally performed for T1 tumour (17 in each group) and mastectomy for T2 tumour (33 in each group). Also irrespective of A and B grouping, radiotherapy including the axilla was given after partial mastectomy, and to women under 70 with T2 tumour and/or lymph-node secondaries. Arm volume and shoulder mobility were measured before and 3, 6 and 12 months after surgery. Arm oedema (greater than or equal to 10% volume increase) was found in 14 group A patients, but none in group B. Twelve of the 14 patients with arm oedema had been irradiated. Subjective sensation of arm swelling in the absence of an objectively measurable increase in arm volume was also more common after axillary dissection plus irradiation than after the other forms of treatment. Impairment of shoulder mobility was more frequent after axillary irradiation.

Entities:  

Mesh:

Year:  1989        PMID: 2603606

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  8 in total

1. 

Authors:  J C Rageth
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

Review 2.  Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift.

Authors:  Aoife Maguire; Edi Brogi
Journal:  Arch Pathol Lab Med       Date:  2016-08       Impact factor: 5.534

3.  Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients.

Authors:  Igor Langer; Ulrich Guller; Gilles Berclaz; Ossi R Koechli; Gabriel Schaer; Mathias K Fehr; Thomas Hess; Daniel Oertli; Lucio Bronz; Beate Schnarwyler; Edward Wight; Urs Uehlinger; Eduard Infanger; Daniel Burger; Markus Zuber
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

Review 4.  Axillary treatment for operable primary breast cancer.

Authors:  Nathan Bromham; Mia Schmidt-Hansen; Margaret Astin; Elise Hasler; Malcolm W Reed
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

5.  Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema.

Authors:  S R Harris; M R Hugi; I A Olivotto; M Levine
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

6.  Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition.

Authors:  Emma C Starritt; David Joseph; J Gregory McKinnon; Sing Kai Lo; Johannes H W de Wilt; John F Thompson
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

7.  Outcomes of shoulder arthroplasty following axillary lymph node dissection.

Authors:  Eric M Padegimas; David Merkow; Thema A Nicholson; Mark D Lazarus; Matthew L Ramsey; Gerald R Williams; Surena Namdari
Journal:  Shoulder Elbow       Date:  2018-06-13

8.  Assessment of morbidity from complete axillary dissection.

Authors:  D Ivens; A L Hoe; T J Podd; C R Hamilton; I Taylor; G T Royle
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.